Vol. 53 (2024): Supplement: Inflammation and finerenone in heart failure with preserved ejection fraction

Este suplemento ha sido financiado a través de una beca sin restricciones de Laboratorio Bayer.

Published: 2024-10-14

Full Issue

• PDF (Spanish)

Editorial

• Introduction

  Eduardo R Perna, Daniel Piskorz

  3-4

  • PDF (Spanish)

Other articles

• Inflammation as therapeutic target in the cardiovascular continuum

  Nicolás Renna, Ezequiel Forte, Sergio Gimenez, Daniel Piskorz

  5-12

  • PDF (Spanish)

• Finerenone in heart failure con mildly reduced and preserved ejection fraction: FINEARTS Study

  Eduardo R Perna, Daniela García Brasca, Felipe Martinez

  13-19

  • PDF (Spanish)